Margaret Shipp

24PUBLICATIONS
181CO-AUTHORS
Haematological tumoursPredictive and prognostic markersHumoural immunology and immunochemistryInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 29, 2026
Impact of EBV Status and Histology on Patient Outcomes with Nivolumab-AVD vs BV-AVD in Advanced Classic Hodgkin Lymphoma (S1826).

|Jun 01, 2026
Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesis.

|May 12, 2026
Laying the Foundation for Clinically Actionable Genomic Subtyping in Diffuse Large B-cell Lymphoma.

|Dec 20, 2025
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors.

Vignesh Shanmugam, Neriman Tokcan, Daniel Chafamo

|Oct 08, 2025
Myeloid landscape profiling identifies DLBCL-specific suppressive macrophages colocalized with blood endothelial cells.

Juliette Ferrant, Simon Le Gallou, Francine Padonou

|Sep 04, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors.

Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder

Pageof 4

Frequent Collaborators

5 joint publications

Robert Redd

5 joint publications

Scott Rodig

4 joint publications

Pier-Luigi Zinzani

3 joint publications

Alex F Herrera